Skip to content
Dose Brief
Menu

Tablet Health review

By Updated

Tablet publishes introductory and renewal prices for compounded injections, but its pharmacy and legal-entity descriptions need clarification before enrollment.

Brief Score45/100Grade CNo. 541 in our directory
Visit Tablet Health View the provider’s current plans and terms.
Semaglutide

$139.99/mo after $89.99 first month

Compounded injection.

3-month plan: $349.99; 6-month plan: $749.99. Confirm payment timing.

Full price details

Compounded injection: $139.99/month after $89.99 first month; 3-month plan $349.99; 6-month plan $749.99

Tirzepatide

$199.99/mo after $129.99 first month

Compounded injection.

3-month plan: $499.99; 6-month plan: $1,099.99. Confirm payment timing.

Full price details

Compounded injection: $199.99/month after $129.99 first month; 3-month plan $499.99; 6-month plan $1,099.99

Coverage
Advertises shipping to all 50 states; confirm eligibility for the selected treatment
Brand-name
Not confirmed

Prices checked against Tablet Health's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Injection rates rise after the first month. Confirm longer-plan payment timing and cancel before the renewal processing deadline, which can precede shipment.

Tablet Health in depth

The price after the first month

Tablet’s compounded injection pages separate the first payment from later months. Semaglutide is $89.99 initially, then $139.99 monthly; tirzepatide is $129.99 initially, then $199.99 monthly. Those ongoing figures are more useful for budgeting than the first-month headlines. Oral versions are also marketed, but they need their own product and price comparison.

Longer plans need payment details

The semaglutide page lists three- and six-month plans at $349.99 and $749.99; tirzepatide lists $499.99 and $1,099.99. Confirm when the full plan amount is charged, the shipment schedule and what happens at renewal. PlexusDx publishes its full annual charges beside its monthly rates, which is the pairing to ask for here. The lower total for one term should not be assumed to apply to another, and a monthly equivalent is not necessarily a monthly payment.

Cancel before processing

Tablet’s terms allow renewal processing ahead of treatment or shipment dates. Cancellation must arrive at least three days before the applicable renewal processing date, with no refund promised for partially used periods. Its refund FAQ also rules out prescription returns and directs problems to support. Use the cancellation checklist before relying on the headline promise to cancel anytime.

Confirm the dispensing pharmacy

The dispensing arrangements need clarification. Tablet’s main page describes its own pharmacies while labeling the NYC location as opening soon. Its separate directory names Pharmacy Hub, Epiq Scripts, Dr. TelX and Emerald Compounding Pharmacy. Ask which legal entity and location will fill your prescription; the directory is not proof that any particular partner supplies your selected GLP-1.

Clarify the operator and state access

The public pages also use different operator names: the footer names Tablet Telehealth Corp, while the telehealth consent identifies Tablet LLC. Ask which entity bills you and which medical practice provides care. The FAQ advertises shipping to all states, but that does not replace confirmation that your particular treatment and clinician are available where you live.

Tablet’s specific product prices are useful, but broad approval and effectiveness language needs caution. References to approved ingredients do not make a compounded drug FDA-approved or equivalent to a branded treatment. Before enrolling, request a written quote and named care team. Badges and a list of partners are not a substitute for those answers.

Sources we checked

Public program pages and terms, checked October 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

Tablet Health scored on our six Brief Score factors. See the methodology.

Price Stability40/100
Supply Reliability57/100
Transparency47/100
Access Breadth36/100
Clinical Oversight50/100
Track Record37/100

What we like

  • Injection product pages distinguish first-month and ongoing prices
  • Public terms describe early renewal processing and cancellation notice
  • Provides a partner-pharmacy directory with physical addresses

The caveats

  • Introductory prices are lower than ongoing monthly charges
  • Public pages use different operator names and describe both own and partner pharmacies
  • Compounded-product marketing should not be read as FDA approval or proven equivalence to a brand

The brief

Best for: Readers comparing oral and injectable offerings who will verify the dispensing pharmacy, treating practice and full subscription terms. Tablet publishes introductory and renewal prices for compounded injections, but its pharmacy and legal-entity descriptions need clarification before enrollment.

Ranked #541 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Tablet Health.

Closest here

The providers scoring nearest Tablet Health — read each current assessment before choosing care.

Weighing Tablet Health against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Tablet Health, and every provider that outranks it is listed on the Tablet Health alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Tablet Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Tablet Health's site. Not medical advice; see our disclosure.

← Back to all rankings